199 related articles for article (PubMed ID: 32453948)
21. Structural disorder in four-repeat Tau fibrils reveals a new mechanism for barriers to cross-seeding of Tau isoforms.
Weismiller HA; Murphy R; Wei G; Ma B; Nussinov R; Margittai M
J Biol Chem; 2018 Nov; 293(45):17336-17348. PubMed ID: 30242125
[TBL] [Abstract][Full Text] [Related]
22. Binding of copper (II) ion to an Alzheimer's tau peptide as revealed by MALDI-TOF MS, CD, and NMR.
Ma QF; Li YM; Du JT; Kanazawa K; Nemoto T; Nakanishi H; Zhao YF
Biopolymers; 2005 Oct; 79(2):74-85. PubMed ID: 15986501
[TBL] [Abstract][Full Text] [Related]
23. Structure of the nonhelical filament of the Alzheimer's disease tau core.
Duan P; Dregni AJ; Mammeri NE; Hong M
Proc Natl Acad Sci U S A; 2023 Oct; 120(44):e2310067120. PubMed ID: 37878719
[TBL] [Abstract][Full Text] [Related]
24. Disclosing the Mechanism of Spontaneous Aggregation and Template-Induced Misfolding of the Key Hexapeptide (PHF6) of Tau Protein Based on Molecular Dynamics Simulation.
Liu H; Zhong H; Liu X; Zhou S; Tan S; Liu H; Yao X
ACS Chem Neurosci; 2019 Dec; 10(12):4810-4823. PubMed ID: 31661961
[TBL] [Abstract][Full Text] [Related]
25. Cofactors are essential constituents of stable and seeding-active tau fibrils.
Fichou Y; Lin Y; Rauch JN; Vigers M; Zeng Z; Srivastava M; Keller TJ; Freed JH; Kosik KS; Han S
Proc Natl Acad Sci U S A; 2018 Dec; 115(52):13234-13239. PubMed ID: 30538196
[TBL] [Abstract][Full Text] [Related]
26. Oxidized and phosphorylated synthetic peptides corresponding to the second and third tubulin-binding repeats of the tau protein reveal structural features of paired helical filament assembly.
Hoffmann R; Dawson NF; Wade JD; Otvös L
J Pept Res; 1997 Aug; 50(2):132-42. PubMed ID: 9273897
[TBL] [Abstract][Full Text] [Related]
27. Copper binding properties of a tau peptide associated with Alzheimer's disease studied by CD, NMR, and MALDI-TOF MS.
Ma Q; Li Y; Du J; Liu H; Kanazawa K; Nemoto T; Nakanishi H; Zhao Y
Peptides; 2006 Apr; 27(4):841-9. PubMed ID: 16225961
[TBL] [Abstract][Full Text] [Related]
28. Site-specific amino acid D-isomerization of Tau R2 and R3 peptides changes the fibril morphology, resulting in attenuation of Tau aggregation inhibitor potency.
Murata T; Ito G; Utsunomiya-Tate N
Biochem Biophys Res Commun; 2023 Apr; 654():18-25. PubMed ID: 36878036
[TBL] [Abstract][Full Text] [Related]
29. Direct Observation of Aggregation-Induced Backbone Conformational Changes in Tau Peptides.
Jiji AC; Shine A; Vijayan V
Angew Chem Int Ed Engl; 2016 Sep; 55(38):11562-6. PubMed ID: 27513615
[TBL] [Abstract][Full Text] [Related]
30. Ordered Assembly of Tau Protein and Neurodegeneration.
Goedert M; Spillantini MG
Adv Exp Med Biol; 2019; 1184():3-21. PubMed ID: 32096024
[TBL] [Abstract][Full Text] [Related]
31. How Does Hyperphopsphorylation Promote Tau Aggregation and Modulate Filament Structure and Stability?
Xu L; Zheng J; Margittai M; Nussinov R; Ma B
ACS Chem Neurosci; 2016 May; 7(5):565-75. PubMed ID: 26854860
[TBL] [Abstract][Full Text] [Related]
32. The distinct structural preferences of tau protein repeat domains.
Li X; Dong X; Wei G; Margittai M; Nussinov R; Ma B
Chem Commun (Camb); 2018 May; 54(45):5700-5703. PubMed ID: 29774342
[TBL] [Abstract][Full Text] [Related]
33. Conformational basis for asymmetric seeding barrier in filaments of three- and four-repeat tau.
Siddiqua A; Luo Y; Meyer V; Swanson MA; Yu X; Wei G; Zheng J; Eaton GR; Ma B; Nussinov R; Eaton SS; Margittai M
J Am Chem Soc; 2012 Jun; 134(24):10271-8. PubMed ID: 22656332
[TBL] [Abstract][Full Text] [Related]
34. Solid-state NMR investigation of the involvement of the P2 region in tau amyloid fibrils.
Savastano A; Jaipuria G; Andreas L; Mandelkow E; Zweckstetter M
Sci Rep; 2020 Dec; 10(1):21210. PubMed ID: 33273615
[TBL] [Abstract][Full Text] [Related]
35. Molecular Insights into the Differential Effects of Acetylation on the Aggregation of Tau Microtubule-Binding Repeats.
Zou Y; Guan L; Tan J; Qi B; Sun Y; Huang F; Zhang Q
J Chem Inf Model; 2024 Apr; 64(8):3386-3399. PubMed ID: 38489841
[TBL] [Abstract][Full Text] [Related]
36. Structural transitions in tau k18 on micelle binding suggest a hierarchy in the efficacy of individual microtubule-binding repeats in filament nucleation.
Barré P; Eliezer D
Protein Sci; 2013 Aug; 22(8):1037-48. PubMed ID: 23740819
[TBL] [Abstract][Full Text] [Related]
37. Protein structural and surface water rearrangement constitute major events in the earliest aggregation stages of tau.
Pavlova A; Cheng CY; Kinnebrew M; Lew J; Dahlquist FW; Han S
Proc Natl Acad Sci U S A; 2016 Jan; 113(2):E127-36. PubMed ID: 26712030
[TBL] [Abstract][Full Text] [Related]
38. Fluent molecular mixing of Tau isoforms in Alzheimer's disease neurofibrillary tangles.
Dregni AJ; Duan P; Xu H; Changolkar L; El Mammeri N; Lee VM; Hong M
Nat Commun; 2022 May; 13(1):2967. PubMed ID: 35624093
[TBL] [Abstract][Full Text] [Related]
39. Binding of the three-repeat domain of tau to phospholipid membranes induces an aggregated-like state of the protein.
Künze G; Barré P; Scheidt HA; Thomas L; Eliezer D; Huster D
Biochim Biophys Acta; 2012 Sep; 1818(9):2302-13. PubMed ID: 22521809
[TBL] [Abstract][Full Text] [Related]
40. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
Stancu IC; Ferraiolo M; Terwel D; Dewachter I
Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]